
Releases
Moderna Executive Patricia Gauthier Joins Decoy Therapeutics Board
At its annual meeting on July 14, Decoy Therapeutics stockholders elected Patricia Gauthier to the company’s board of directors. Gauthier, a seasoned biopharmaceutical executive currently leading regional operations for Moderna, joins the board as the Cambridge-based firm prepares to transition its D-MAV antiviral platform toward clinical testing.


























